Journal
CLINICAL CANCER RESEARCH
Volume 20, Issue 18, Pages 4733-4736Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-14-0818
Keywords
-
Categories
Funding
- NCI NIH HHS [R01 CA183857, R01-CA-183857-01] Funding Source: Medline
Ask authors/readers for more resources
Molecular prostate cancer subtypes have been proposed on the basis of mutually exclusive SPINK1 and ERG overexpression, with conflicting reports on their prognostic ability. Flavin and colleagues report that SPINK1 is neither prognostic nor absolutely mutually exclusive with ERG, raising important questions about prostate cancer molecular subtyping and prognostic biomarker evaluation. (C)2014 AACR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
